Tim Krohne, Alimera Sciences (C), Alimera Sciences (R), Bayer (C), Bayer (R), Heidelberg Engineering (R), Novartis (F), Novartis (C), Novartis (R);
Petra Fang, None;
Akio Oishi, Alcon (F), Bayer (R), Novartis (R);
Seleman Bedar, None;
Philipp Heymer, None;
Christoph Clemens, Bayer (F), Bayer (C), Bayer (R), Heidelberg Engineering (R), Novartis (F), Novartis (C), Novartis (R);
Susanna König, None;
Nicole Eter, Alimera Sciences (C), Allergan (F), Allergan (C), Bausch + Lomb (C), Bayer (F), Bayer (C), Bayer (R), Heidelberg Engineering (R), Novartis (F), Novartis (C), Novartis (R), Roche (C);
Armin Wolf, Bayer (F), DORC (R), Gensight (F), Novartis (F), Novartis (C), Novartis (R), Oertli (R), Ophthotech (F), Optos (C), Optos (R), Roche (F);
Frank Holz, Acucela (F), Acucela (C), Allergan (F), Allergan (R), Bayer (F), Bayer (C), Bayer (R), Bioeq (F), Bioeq (C), Boehringer-Ingelheim (C), Genentech (F), Genentech (C), Heidelberg Engineering (F), Heidelberg Engineering (C), Merz (C), NightstarX (F), Novartis (F), Novartis (C), Novartis (R), Optos (F), Pixium (F), Roche (F), Roche (C), Thea (C), Zeiss (F)